Patent ID: 11919951
Assignee: TRON—TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITäTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITäT MAINZ
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 14:
15. The antibody or antigen-binding fragment thereof of claim 1, wherein said antibody or antigen-binding fragment thereof is selected from the group consisting of:
(i) an antibody produced by or obtainable from a clone deposited under the accession no. DSM ACC3313 (58-1B), DSM ACC3312 (58-3A) or DSM ACC3311 (58-4B-2),
(ii) an antibody which is a chimerized or humanized form of the antibody under (i),
(iii) an antibody which competes for CLDN6 binding with an antibody under (i),
(iv) an antibody which has the specificity of the antibody under (i),
(v) an antibody comprising the antigen binding portion or antigen binding site of the antibody under (i), and
(vi) an antigen-binding fragment of the antibody of (i), (ii), (iii), (iv), or (v).